South Dakota statute
SDCL § 34-20B-25 — Substances included in Schedule IV
Current through text effective June 30, 2026 (through the 2025 Regular Session)
Part of Chapter 20B: Drugs And Substances Control, South Dakota Codified Laws.
Full text of SDCL § 34-20B-25
Statutory text current through the text effective June 30, 2026 (through the 2025 Regular Session). This publication reproduces the official statutory text; it is not the official statutes of the State of South Dakota.
The following are included in Schedule IV:
(1) Chlordiazepoxide, but not including librax (chlordiazepoxide hydrochloride and clindinium bromide) or menrium (chlordiazepoxide and water soluble esterified estrogens);
(2) Clonazepam;
(3) Clorazepate;
(4) Diazepam;
(5) Flunitrazepam;
(6) Flurazepam;
(7) Mebutamate;
(8) Oxazepam;
(9) Prazepam;
(10) Lorazepam;
(11) Triazolam;
(12) Any substance that contains any quantity of a benzodiazepine, or salt of benzodiazepine, except substances that are specifically listed in other schedules;
(13) Alprazolam;
(14) Midazolam;
(15) Temazepam;
(16) Cathine;
(17) Fencamfamine;
(18) Fenproporex;
(19) Mefenorex;
(20) Pyrovalerone;
(21) Propoxyphene;
(22) Pentazocine;
(23) Diethylpropion;
(24) Ethchlorvynol;
(25) Ethinamate;
(26) Mazindol;
(27) Mephobarbital;
(28) Methohexitol;
(29) Paraldehyde;
(30) Pemoline;
(31) Petrichloral;
(32) Phentermine;
(33) Barbital;
(34) Phenobarbital;
(35) Meprobamate;
(36) Zolpidem;
(37) Butorphanol;
(38) Modafinil, including its salts, isomers, and salts of isomers;
(39) Sibutramine;
(40) Zaleplon;
(41) Dichloralphenazone;
(42) Zopiclone, also known as eszopiclone, including its salts, isomers, and salts of isomers;
(43) Pregabalin;
(44) Lacosamide;
(45) Fospropofol, including its salts, isomers, and salts of isomers;
(46) Clobazam;
(47) Carisoprodol, including its salts, isomers, and salts of isomers;
(48) Ezogabine,[-[2-amino-4-(4-fluorobenzylamino)-phenyl]-carbamic acid ethyl ester], including its salts, isomers, and salts of isomers;
(49) Lorcaserin, any material, compound, mixture, or preparation that contains any quantity of the following substances, including its salts, isomers, and salts of isomers, whenever the existence of such salts, isomers, and salts of isomers is possible;
(50) Alfaxalone, 5[alpha]-pregnan-3[alpha]-ol-11,20-dione, including its salts, isomers, and salts of isomers;
(51) Tramadol, 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers;
(52) Suvorexant, including its salts, isomers, and salts of isomers;
(53) Eluxadoline,(5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) including its optical isomers and its salts, isomers, and salts of isomers;
(54) Brivaracetam;
(55) Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester)), including its salts, isomers, and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible;
(56) Brexanolone, (3[alpha]-hydroxy-5[alpha]-pregnan-20-one), including its salts, isomers, and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible;
(57) Cenobamate ([(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl] carbamate; 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1-(2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester);
(58) Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl)-benzamide];
(59) Lemborexant, including its salts, isomers, and salts of isomers;
(60) Remimazolam;
(61) Serdexmethylphenidate, including its salts, isomers, and salts of isomers;
(62) Daridorexant, including its salts, isomers, and salts of isomers;
(63) Ganaxolone, including its salts;
(64) Zuranolone; and
(65) The pharmaceutical composition of crystalline polymorph psilocybin in a drug product approved by the United States Food and Drug Administration.
Official sources
Legal terms used in this section
This reference is informational and is not legal advice.